Dr. Michael Needle
Now over to Boulder, Colorado where biopharmaceutical company Array BioPharma has appointed a new Chief Medical Officer in the form of Dr. Michael Needle - a man with over 14 years of experience in the drug development and regulatory fields.
“With Array's focus in blood cancers and solid tumors, Dr. Needle's prior experience at ImClone, Celgene and more recently the Multiple Myeloma Research Foundation will be invaluable,” said Ron Squarer, CEO of ArrayPharma.